Four cases of acute proctocolitis associated with non-steroidal anti-inflammatory drug therapy are presented. The drugs implicated were flufenamic acid, mefenamic acid, naproxen and ibuprofen. After resolution of symptoms and signs of proctocolitis three of the four patients were subsequently rechallenged with the implicated drug: in each there was a rapid relapse.
Introduction
Ulcerative colitis is a disease of unknown aetiology with characteristic clinical features and a protracted course. A similar clinical picture, but running a shorter and usually benign course, is occasionally seen following the administration of certain drugs. This was first noticed following the administration of antibiotics, often with pseudomembrane formation. Later, this was shown to be associated with infection by toxigenic Clostridium difficile. Until 1978, most cases were associated with treatment with clindamycin but since that time nearly all antibiotics have been implicated. Other drugs capable of causing proctocolitis, though by different mechanisms, include phenindione (Keat & Tanser, 1966) , penicillamine (Hickling & Fulbi, 1979) , gold salts (Fami et al., 1980) , methyl dopa (Graham et al., 1981) , cimetidine (Collins, 1982) and methotrexate (Atherton et al., 1984) . Inflammatory bowel disease resembling Crohn's disease, though nearly always with rectal sparing, has also been associated with oral contraceptives (Tedesco et al., 1982) .
In contrast to non-specific diarrhoea, which is a well-known side effect of anti-rheumatic medication, ulcerative proctocolitis has been associated with ingestion of salicylate (Pearson et al., 1983) and mefenamic acid (Hall et al., 1983; Phillips et al., 1983; Edwards et al., 1983; Rampton & Tapping, 1983; Williams & Glazier, 1983) usually after prolonged exposure to the drug. We report four cases of proctocolitis in which three further non-steroidal anti-inflammatory drugs (NSAIDs) are implicated. In three out of four cases colitis recurred on rechallenge. None of the patients had suffered from colitis previously. Possible mechanisms of induction of colitis are briefly discussed.
Case reports
Case I A 77 year old woman was referred with intermittent bleeding per rectum for 6 months, associated for the last 2 months with bloody diarrhoea up to eight times daily. Previously, she had had troublesome symptoms from osteoarthritis of her back and knees for which she had been prescribed flufenamic acid 200 mg thrice daily. Her general health had remained good but she appeared pale and her haemoglobin was reduced to 8 g/dl. Apart from osteoarthritis at the knees there were no abnormal physical signs. Sigmoidoscopy revealed an inflamed, bleeding mucosa in the rectum and sigmoid colon and rectal biopsy showed heavy mucosal infiltration with lymphocytes and plasma cells. Stool cultures were negative for bacterial and fungal pathogens and parasites and a barium enema showed loss of haustration in the descending and sigmoid colon. Flufenamic acid was discontinued and after 2 weeks her bowels had returned to normal with a dramatic improvement in the sigmoidoscopic appearances. She was subsequently re-challenged with 200 mg of flufenamic acid daily; she discontinued the tablets after 48 hours because of recurrence of diarrhoea.
Case 2
A 73 year old woman complained of diarrhoea for 3 months with six to seven bowel actions daily associated with tenesmus and the passage ofblood and mucus. Previously, she had complained of painful knees and 9 days before the onset ofdiarrhoea, she had been prescribed mefenamic acid 500mg t. (Coutrot et al., 1978; Schwartz, 1981 ) though in our case the predominant disease was proctocolitis. The time interval from starting the drug to the onset of diarrhoea varied from 2 days to 4 months but the three patients who were re-challenged relapsed within 72 hours. On follow-up all remained well and free of bowel symptoms. Vane in 1971 first proposed that the action of NSAIDs involved the inhibition of prostaglandin synthesis and the four drugs implicated in these cases are all potent inhibitors of prostaglandin synthesis. As mucosal prostaglandins are known to be increased in active ulcerative colitis (Sharon et al., 1978) and may play some part in the inflammatory response in this condition, drugs ofthis kind might be expected to have a beneficial effect on the mucosa. Indeed, sulphasalazine and its cleavage product 5-aminosalicylic acid both inhibit prostaglandin synthesis in the rectal mucosa, at high concentrations, although they are less potent inhibitors than indomethacin or flurbiprofen (Hawkey & Truelove, 1983) .
However, Levy & Gaspar (1975) reported proctitis occurring after the use of indomethacin suppositories, the severity of which appeared to be related to the dose. In individuals known to have ulcerative colitis attempts to lower prostaglandin levels in the gut with a short course of oral flurbiprofen, compared with conventional treatment, showed that the patients given flurbiprofen fared significantly worse (Rampton & Sladen, 1981) . Others have shown that local treatment with indomethacin retention enemas failed to produce improvement in distal proctocolitis (Gilat et al., 1979) . Furthermore, ibuprofen has been reported to be associated with an acute relapse of ulcerative colitis after only six tablets (Walt et al., 1984) . Rampton & Sladen (1980) reported four patients with inactive ulcerative proctocolitis in whom the administration of NSAIDs appeared to precipitate relapse and proposed that this might be due to inhibition of synthesis of prostaglandins which may be playing a protective role in the mucosa. Relapse of quiescent ulcerative colitis appears to occur fairly quickly after NSAIDs but in those without underlying colitis, the time interval is more variable. This would be consistent with the speed of onset of diarrhoea following rechallenge in our cases.
It is now recognized that, in addition to their involvement in tissue-damaging inflammatory reactions, prostaglandins exert a protective effect on the gastric mucosa when exposed to necrotizing agents such as absolute alcohol and to NSAIDs such as aspirin. This property has been termed cytoprotection by Robert (1979) . Mucosal inflammation could result therefore from reduced synthesis of cytoprotective prostaglandins. Alternatively, this may be due to enhancement of intestinal permeability by the NSAIDs thus allowing antigenic material within the lumen increased access to the immune system (Bjarnason et al., 1984) .
Although these four cases are uncommon, NSAIDs may cause serious inflammatory bowel disease. Mucosal damage may result from impairment of local prostaglandin synthesis and disturbance of the equilibrium between the cyclo-and lipoxygenase pathways of arachidonic acid metabolism. The development of more specific inhibitors of inflammatory factors and drugs which enhance cytoprotection will be of great value to the clinician.
